Pfizer has chosen Kudos, a research showcasing platform, to enhance the dissemination of its scientific publications. Kudos will host clinical summaries and links to related content like peer-reviewed articles, infographics, conference posters, videos, and fact sheets.
Initial focus areas include Inflammation and Immunology, Internal Medicine, and Vaccines. Pfizer's content will be summarized and featured alongside prestigious research from Kudos' academic publisher and university partners. By centralizing discovery and guiding audiences through a curated content journey, Kudos will significantly boost Pfizer's visibility. The Kudos platform also offers a robust suite of metrics, including publication citation counts, views of related content, and audience insights.
The agreement reflects a shared commitment to enhancing the transparency, accessibility, and real-world impact of medical publications.
Click here to read the original press release.
